Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
Vaccine ; 19(6): 655-60, 2000 Nov 08.
Article in English | MEDLINE | ID: mdl-11090718

ABSTRACT

Fragilysin, an extracellular zinc metalloprotease produced by enterotoxigenic strains of the anaerobic bacterium Bacteroides fragilis, disrupts the paracellular barrier by cleavage of the intercellular proteins between epithelial cells resulting in fluid secretion. Intranasal immunization of mice with fragilysin and co-administered ovalbumin (Ova) resulted in an Ova-specific serum IgG response that was over 18000-fold higher than Ova alone, as well as detectable levels of serum IgA. Serum IgG titers were comparable with those seen when whole cholera toxin was used as the adjuvant, although the responses obtained with fragilysin showed more variability between mice. Metalloproteases to which fragilysin is structurally related were ineffective as mucosal adjuvants. Our results and similar studies with enterotoxins that affect the paracellular barrier suggest that alteration of mucosal permeability may play an important role in the mechanisms of adjuvanticity.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Administration, Intranasal , Antigens, Bacterial/immunology , Immunoglobulins/blood , Metalloendopeptidases/immunology , Animals , Animals, Outbred Strains , Antibodies, Bacterial/biosynthesis , Cholera Toxin/administration & dosage , Cholera Toxin/immunology , Female , Immunity, Mucosal , Metalloendopeptidases/administration & dosage , Mice , Mice, Inbred BALB C , Ovalbumin/immunology , Vaccination
3.
J Clin Microbiol ; 38(8): 3072-5, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10921980

ABSTRACT

Toxin-specific enzyme immunoassays, cytotoxicity assays, and PCR were used to analyze 48 toxin A-negative, toxin B-positive Clostridium difficile isolates from various geographical sites around the world. All the isolates were negative by the TOX-A TEST and positive by the TOX A/B TEST. A deletion of approximately 1.7 kb was found at the 3' end of the toxA gene for all the isolates, similar to the deletion in toxinotype VIII strains (e.g., C. difficile serotype F 1470). Additional PCR analysis indicated that the toxin B encoded by these isolates contains sequence variations downstream of the active site compared to the sequence of reference strain VPI 10463. This variation may extend the glucosylation spectrum to Ras proteins, as observed previously for closely related lethal toxin from Clostridium sordellii and toxin B from toxin A-negative, toxin B-positive strain F 1470. Toxin A-negative, toxin B-positive isolates have recently been associated with disease in humans, and they may be more common than was previously supposed.


Subject(s)
Bacterial Proteins , Bacterial Toxins/genetics , Clostridioides difficile/genetics , Enterotoxins/genetics , Polymerase Chain Reaction , Bacterial Toxins/metabolism , Clostridioides difficile/isolation & purification , Clostridioides difficile/metabolism , Enterocolitis, Pseudomembranous/microbiology , Enterotoxins/metabolism , Genes, Bacterial , Humans , Immunoenzyme Techniques
4.
Infect Immun ; 68(4): 2161-6, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10722615

ABSTRACT

Unlike the native protein, a nontoxic peptide (repeating unit of the native toxin designated rARU) from Clostridium difficile toxin A (CDTA) afforded an antigen that could be bound covalently to the surface polysaccharides of pneumococcus type 14, Shigella flexneri type 2a, and Escherichia coli K1. The yields of these polysaccharide-protein conjugates were significantly increased by prior treatment of rARU with succinic anhydride. Conjugates, prepared with rARU or succinylated (rARUsucc), were administered to mice by a clinically relevant dosage and immunization scheme. All conjugates elicited high levels of serum immunoglobulin G both to the polysaccharides and to CDTA. Conjugate-induced anti-CDTA had neutralizing activity in vitro and protected mice challenged with CDTA, similar to the rARU alone. Conjugates prepared with succinylated rARU, therefore, have potential for serving both as effective carrier proteins for polysaccharides and for preventing enteric disease caused by C. difficile.


Subject(s)
Bacterial Toxins/immunology , Carrier Proteins/immunology , Clostridioides difficile/immunology , Enterotoxins/immunology , Escherichia coli/immunology , Polysaccharides, Bacterial/immunology , Shigella flexneri/immunology , Streptococcus pneumoniae/immunology , Vaccines, Conjugate/immunology , Animals , Bacterial Toxins/genetics , Carbohydrate Sequence , Enterotoxins/genetics , Enzyme-Linked Immunosorbent Assay , Female , Immunoglobulin G/blood , Immunoglobulin M/blood , Mice , Molecular Sequence Data , Polysaccharides, Bacterial/metabolism , Recombinant Proteins/immunology , Succinic Anhydrides/metabolism , Vaccines, Conjugate/chemistry
5.
Infect Immun ; 66(4): 1735-9, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9529104

ABSTRACT

Enterotoxigenic strains of Bacteroides fragilis produce an extracellular metalloprotease toxin (termed fragilysin) which is cytopathic to intestinal epithelial cells and induces fluid secretion and tissue damage in ligated intestinal loops. We report here that the fragilysin gene is contained within a small genetic element termed the fragilysin pathogenicity islet. The pathogenicity islet of B. fragilis VPI 13784 was defined as 6,033 bp in length and contained nearly perfect 12-bp direct repeats near its ends. Sequencing across the ends of the pathogenicity islet from two additional enterotoxigenic strains, along with PCR analysis of 20 additional enterotoxigenic strains, revealed that the islet is inserted at a specific site on the B. fragilis chromosome. The site of integration in three nontoxigenic strains contained a 17-bp GC-rich sequence which was not present in toxigenic strains and may represent a target sequence for chromosomal integration. In addition to the fragilysin gene, we identified an open reading frame encoding a predicted protein with a size and structural features similar to those of fragilysin. The deduced amino acid sequence was 28.5% identical and 56.3% similar to fragilysin and contained a nearly identical zinc-binding motif and methionine-turn region.


Subject(s)
Bacteroides fragilis/pathogenicity , Enterotoxins/genetics , Metalloendopeptidases/genetics , Amino Acid Sequence , Base Sequence , Metalloendopeptidases/chemistry , Molecular Sequence Data , Open Reading Frames , Polymerase Chain Reaction
6.
Infect Immun ; 65(3): 1105-8, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9038324

ABSTRACT

The toxigenic element of Clostridium difficile VPI 10463 contains a small open reading frame (ORF) immediately upstream of the toxin B gene (G. A. Hammond and J. L. Johnson, Microb. Pathog. 19:203-213, 1995). The deduced amino acid sequence of the ORF, which we have designated txeR, encodes a 22-kDa protein which contains a helix-turn-helix motif with sequence identity to DNA binding regulatory proteins. We used a DNA fragment containing the C. difficile toxin A repeating units (ARU) as a reporter gene to determine if txeR regulates expression from the toxin A and toxin B promoters in Escherichia coli. To test the affect of txeR on expression, we fused the ARU gene fragment in frame with the toxin promoters. The fusions expressed a 104-kDa protein that contained the epitopes for monoclonal antibody PCG-4, which we used to measure levels of recombinant ARU by enzyme-linked immunosorbent assay. When txeR was expressed in trans with the toxin B promoter-ARU fusion contained on separate low-copy-number plasmid, expression of ARU increased over 800-fold. Furthermore, when we tested the toxin A promoter fused to ARU, expression increased over 500-fold with txeR supplied in trans. Our results suggest that TxeR is a positive regulator that activates expression of the C. difficile toxins.


Subject(s)
Bacterial Proteins , Bacterial Toxins/genetics , Clostridioides difficile/pathogenicity , Enterotoxins/genetics , Gene Expression Regulation, Bacterial , Promoter Regions, Genetic , Amino Acid Sequence , Clostridioides difficile/genetics , Molecular Sequence Data
7.
FEMS Microbiol Lett ; 146(2): 279-84, 1997 Jan 15.
Article in English | MEDLINE | ID: mdl-9011050

ABSTRACT

The Bacteroides fragilis enterotoxin is an extracellular zinc metalloprotease that has been implicated in diarrheal disease of humans and animals. This toxin causes fluid accumulation in intestinal loops and is cytotoxic for HT-29 cells, an intestinal carcinoma cell line. Here we report the cloning and sequencing of the toxin gene (bftP). bftP is 1191 nucleotides coding for a 397 amino acid protein of 44.4 kDa. The toxin has a signal peptide of 18 amino acids that is typical of many lipoproteins followed by a 379 amino acid protoxin. The portion of the protoxin found in culture filtrates and stools begins at amino acid 212. An additional open reading frame located immediately upstream shows some sequence identity with cobra cytotoxins. If expressed, the ORF protein product could also play a role in the virulence of B. fragilis.


Subject(s)
Bacteroides fragilis/genetics , Enterotoxins/genetics , Metalloendopeptidases/genetics , Amino Acid Sequence , Bacterial Proteins/genetics , Bacteroides fragilis/enzymology , Base Sequence , Cloning, Molecular , DNA, Bacterial/analysis , DNA, Bacterial/isolation & purification , Molecular Sequence Data , Open Reading Frames/genetics , Sequence Analysis, DNA
8.
Infect Immun ; 63(1): 175-81, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7806355

ABSTRACT

During the past decade, strains of Bacteroides fragilis that produce an enterotoxin have been implicated in diarrheal disease in animals and humans. The extracellular enterotoxin has been purified and characterized as a single polypeptide (M(r), approximately 20,000). Single specific primer-PCR was used to clone a portion of the B. fragilis enterotoxin gene. The recombinant protein expressed by the cloned gene fragment reacted with monospecific antibodies to B. fragilis enterotoxin by enzyme-linked immunosorbent assay and immunoblot analysis. The deduced amino acid sequence revealed a signature zinc-binding consensus motif (HEXXHXXGXXH/Met-turn) characteristic of metalloproteases termed metzincins. Sequence comparisons showed close identity to matrix metalloproteases (e.g., human fibroblast collagenase) within the zinc-binding and Met-turn region. Purified enterotoxin contained 1 g-atom of Zn2+ per molecule and hydrolyzed gelatin, azocoll, actin, tropomyosin, and fibrinogen. The enterotoxin also underwent autodigestion. The N-terminal amino acid sequences of two autodigestion products were identical to the deduced amino acid sequence of the recombinant enterotoxin and revealed cleavage at Cys-Leu and Ser-Leu peptide bonds. Gelatinase (type IV collagenase) activity comigrated with the toxin when analyzed by gel fractionation and zymography, indicating that protease activity is due to the enterotoxin and not to a contaminating protease(s). Optimal proteolytic activity occurred at 37 degrees C and pH 6.5. Primary proteolytic cleavage sites in actin were identified, revealing cleavage at Gly-Met and Thr-Leu peptide bonds. Enzymatic activity was inhibited by metal chelators but not by inhibitors of other classes of proteases. Additionally, cytotoxic activity of the enterotoxin on human carcinoma HT-29 cells was inhibited by acetoxymethyl ester EDTA. The metalloprotease activity of the enterotoxin suggests a possible mechanism for enterotoxicity and may have additional implications in the study of disease caused by B. fragilis.


Subject(s)
Bacterial Toxins/metabolism , Bacteroides fragilis/enzymology , Metalloendopeptidases/metabolism , Actins/metabolism , Amino Acid Sequence , Azo Compounds/metabolism , Bacterial Toxins/genetics , Bacterial Toxins/immunology , Bacteroides fragilis/genetics , Base Sequence , Cloning, Molecular , Collagen/metabolism , Collagenases/metabolism , Consensus Sequence , Escherichia coli/genetics , Genes, Bacterial/genetics , Metalloendopeptidases/antagonists & inhibitors , Metalloendopeptidases/genetics , Metalloendopeptidases/immunology , Molecular Sequence Data , Polymerase Chain Reaction/methods , Recombinant Proteins/immunology , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Substrate Specificity , Zinc/analysis
9.
Microb Pathog ; 16(4): 297-303, 1994 Apr.
Article in English | MEDLINE | ID: mdl-7968458

ABSTRACT

Toxins A and B of Clostridium difficile are large cytotoxic proteins that share several unusual structural features, including four conserved cysteines, a potential nucleotide binding site, a hydrophobic region, and a series of contiguous repeating units at the carboxyl terminus. In the following study, we developed a series of toxin B mutants with altered properties in each of these features and examined the effect of the mutation on cytotoxic activity. Altering conserved cysteines to serine resulted in a 90% reduction in activity, whereas altering a histidine residue located in the potential nucleotide binding site to glutamine resulted in a 99% reduction. Removing the repeating units lowered the activity by 90% whereas removing the repeating units plus a conserved cysteine located just upstream of the units reduced the activity by more than five logs, resulting in an inactive toxin. Deleting the internal hydrophobic region had a similar effect. Our findings demonstrate that these conserved features appear to be important for expression of cytotoxic activity.


Subject(s)
Bacterial Proteins , Bacterial Toxins/genetics , Bacterial Toxins/toxicity , Clostridioides difficile/chemistry , Sequence Deletion/physiology , Amino Acid Sequence , Animals , CHO Cells , Clostridioides difficile/genetics , Cricetinae , Cysteine/physiology , Enterotoxins/genetics , Escherichia coli/genetics , Genes, Bacterial/genetics , Histidine/physiology , Molecular Sequence Data , Mutagenesis, Site-Directed
SELECTION OF CITATIONS
SEARCH DETAIL